⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL126899 | 0.80 | — | — | |
| SCHEMBL969161 | 0.80 | — | — | |
| SCHEMBL23036848 | 0.71 | CA9 (0.41) | — | |
| SCHEMBL23388092 | 0.71 | HPGD (0.48) | — | |
| SCHEMBL23036843 | 0.71 | HPGD (0.45) | — | |
| SCHEMBL743014 | 0.71 | HPGD (0.53) | — | |
| SCHEMBL16447347 | 0.71 | HPGDS (0.40) | — | |
| SCHEMBL2440695 | 0.70 | — | — | |
| SCHEMBL23213100 | 0.70 | HDAC4 (0.38) | — | |
| SCHEMBL23388069 | 0.69 | VNN1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230028441-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | ELANCO ANIMAL HEALTH GMBH (DE) | 2023-01-26 | — | — | US | claimed |
| CN-114867529-A | Novel heteroaryl triazole compounds as pesticides | 拜耳公司 | 2022-08-05 | — | — | CN | claimed |
| WO-2021069567-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-04-15 | — | — | WO | claimed |
| CN-110746479-B | Compound and preparation method and application thereof | 山东师范大学 | 2021-01-08 | — | — | CN | claimed |
| CN-110746479-A | Compound and preparation method and application thereof | 山东师范大学 | 2020-02-04 | — | — | CN | claimed |
| US-9682940-B2 | Indazole derivatives useful as CB-1 inverse agonists | JANSSEN PHARMACEUTICA NV (BE) | 2017-06-20 | — | — | US | claimed |
| WO-2017034872-A1 | INDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-02 | — | — | WO | claimed |
| US-20170057925-A1 | INDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2017-03-02 | — | — | US | claimed |
| US-9249163-B2 | PDE10a inhibitors for the treatment of type II diabetes | JANSSEN PHARMACEUTICA NV. (BE) | 2016-02-02 | — | — | US | claimed |
| WO-2014200885-A1 | PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES | JANSSEN PHARMACEUTICA NV (BE) | 2014-12-18 | — | — | WO | claimed |
| US-4711951-A | Therapeutically active compound and pharmaceutical composition containing the same | PHARMACIA AKTIEBOLAG (SE) | 1987-12-08 | — | — | US | claimed |
| US-4709037-A | Biotinylating agents | HOECHST CELANESE CORPORATION (US) | 1987-11-24 | — | — | US | claimed |
| EP-0208776-A1 | CARRIER-BOUND HISTAMINE, ITS MANUFACTURE AND ITS USE | PHARMACIA AB (SE) | 1987-01-21 | — | — | EP | claimed |
| WO-1986004331-A1 | CARRIER-BOUND HISTAMINE, ITS MANUFACTURE AND ITS USE | PHARMACIA AB (SE) | 1986-07-31 | — | — | WO | claimed |
| EP-0063109-B1 | THERAPEUTICALLY ACTIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PHARMACIA AB (SE) | 1986-07-16 | — | — | EP | claimed |
| EP-0064040-B1 | THERAPEUTICALLY ACTIVE DISULPHIDE COMPOUNDS AND THEIR USE | PHARMACIA AKTIEBOLAG (SE) | 1985-08-28 | — | — | EP | claimed |
| EP-0064040-A1 | Therapeutically active disulphide compounds and their use | PHARMACIA AKTIEBOLAG (SE) | 1982-11-03 | — | — | EP | claimed |
| EP-0063109-A2 | Therapeutically active compound and pharmaceutical composition containing the same | PHARMACIA AB (SE) | 1982-10-20 | — | — | EP | claimed |
| WO-1982003395-A1 | THERAPEUTICALLY ACTIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PHARMACIA AB (SE) | 1982-10-14 | — | — | WO | claimed |
| WO-1982003394-A1 | THERAPEUTICALLY ACTIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PHARMACIA AB (SE) | 1982-10-14 | — | — | WO | claimed |